Ocular Therapeutix, Inc. (OCUL)
8.86
+0.45
(+5.35%)
USD |
NASDAQ |
Feb 24, 11:32
Ocular Therapeutix Market Cap : 1.929B for Feb. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals, Inc. | 82.26B |
| Boston Scientific Corp. | 110.19B |
| Alnylam Pharmaceuticals, Inc. | 43.77B |
| EyePoint Plc | 1.407B |
| Vertex Pharmaceuticals, Inc. | 123.68B |
Market Cap Related Metrics
| PS Ratio | 31.93 |
| PEG Ratio | -0.4398 |
| Price to Book Value | 2.948 |
| Price | 8.86 |
| Earnings Yield | -16.23% |
| PEGY Ratio | -0.4398 |